Vaccine Therapy in Treating Patients With Advanced Melanoma

Clinical trial NCT00705640 · COMPLETED

Trial details

NCT number: NCT00705640
Sponsor: Craig L Slingluff, Jr
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Intraocular Melanoma Malignant Conjunctival Neoplasm Melanoma (Skin)

Start date: 2008-05-01
Primary completion: 2009-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.